NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CG labs segment comprises the CG Converting and Packaging, LLC used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its hydrogel consumer products are marketed under the brand names MedaGel and LumaGel Beauty. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. It also specializes in eye and eyelash consumer products.
BörsenkürzelNXGL
Name des UnternehmensNexgel Inc
IPO-datumDec 22, 2021
CEOMr. Adam Levy
Anzahl der mitarbeiter19
WertpapierartOrdinary Share
GeschäftsjahresendeDec 22
Addresse2150 Cabot Blvd West,
StadtLANGHORNE
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl19047
Telefon12157028550
Websitehttps://nexgel.com/
BörsenkürzelNXGL
IPO-datumDec 22, 2021
CEOMr. Adam Levy
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten